selpercatinib
Showing 1 - 25 of 27
Healthy Trial in Dallas (Rosuvastatin, Selpercatinib)
Not yet recruiting
- Healthy
- Rosuvastatin
- Selpercatinib
-
Dallas, TexasLabcorp Clinical Research LP
Jun 8, 2023
Healthy Trial in Madison ([14C] Selpercatinib, Selpercatinib)
Completed
- Healthy
- [14C] Selpercatinib
- Selpercatinib
-
Madison, WisconsinLabCorp CRU, Inc.
Nov 21, 2022
Thyroid Cancer, Thyroid Carcinoma, Metastatic Thyroid Cancer Trial in Boston (Selpercatinib, Sodium Iodine I-131, rhTSH)
Not yet recruiting
- Thyroid Cancer
- +5 more
- Selpercatinib
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital
Dec 20, 2022
Malignant Thyroid Gland Tumor, Poorly Differentiated Thyroid Gland Carcinoma, Recurrent Thyroid Gland Carcinoma Trial in Houston
Recruiting
- Malignant Thyroid Gland Neoplasm
- +6 more
- Quality-of-Life Assessment
- +3 more
-
Ann Arbor, Michigan
- +1 more
Jan 24, 2023
Healthy Trial in Singapore (Selpercatinib)
Completed
- Healthy
- Selpercatinib
-
Singapore, SingaporeLilly Centre for Clinical Pharmacology
Jul 12, 2022
Healthy Trial in United States (Selpercatinib)
Completed
- Healthy
- Selpercatinib
-
Anaheim, California
- +3 more
Aug 17, 2022
Healthy Trial in Tempe (Selpercatinib, Moxifloxacin, Placebo)
Completed
- Healthy
- Selpercatinib
- +2 more
-
Tempe, ArizonaCelerion
Nov 21, 2022
Healthy Trial in Madison (Selpercatinib, Ranitidine, Omeprazole)
Completed
- Healthy
- Selpercatinib
- +2 more
-
Madison, WisconsinCovance Clinical Research Unit, Inc.
Jan 12, 2023
Healthy Trial in Daytona Beach (Selpercatinib)
Completed
- Healthy
- Selpercatinib
-
Daytona Beach, FloridaLabCorp CRU, Inc.
Apr 14, 2022
Healthy Trial in Tempe (Selpercatinib)
Completed
- Healthy
- Selpercatinib
-
Tempe, ArizonaCelerion
Apr 19, 2022
Healthy Trial in Tempe (Selpercatinib, Itraconazole, Rifampin)
Completed
- Healthy
- Selpercatinib
- +2 more
-
Tempe, ArizonaCelerion
Apr 19, 2022
Healthy, Renal Insufficiency Trial in United States (Selpercatinib)
Completed
- Healthy
- Renal Insufficiency
- Selpercatinib
-
Anaheim, California
- +5 more
Jul 20, 2022
Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial in Tampa
Recruiting
- Lung Non-Small Cell Carcinoma
- +4 more
- Carboplatin
- +2 more
-
Tampa, FloridaMoffitt Cancer Center
Aug 16, 2022
Solid Tumor, Medullary Thyroid Cancer Trial in China (Selpercatinib)
Active, not recruiting
- Solid Tumor
- Medullary Thyroid Cancer
- Selpercatinib
-
Guangzhou, Guangdong, China
- +12 more
May 9, 2022
Healthy, Hepatic Impairment Trial in United States (Selpercatinib)
Completed
- Healthy
- Hepatic Impairment
- Selpercatinib
-
Anaheim, California
- +6 more
Jun 24, 2022
Healthy Trial in Daytona Beach (Dabigatran, Selpercatinib)
Completed
- Healthy
- Dabigatran
- Selpercatinib
-
Daytona Beach, FloridaCovance Clinical Research Inc
Jul 15, 2021
Advanced Cancer, Solid Tumor Trial in Helsinki, Kuopio, Tampere (Alectinib, Cobimetinib, Vismodegib)
Recruiting
- Advanced Cancer
- Solid Tumor
- Alectinib
- +13 more
-
Helsinki, Uusimaa, Finland
- +2 more
Jun 8, 2022
Medullary Thyroid Cancer Trial in Worldwide (Selpercatinib, Cabozantinib, Vandetanib)
Recruiting
- Medullary Thyroid Cancer
- Selpercatinib
- +2 more
-
Birmingham, Alabama
- +148 more
Jan 18, 2023
NSCLC Trial in Worldwide (Selpercatinib, Carboplatin, Cisplatin)
Active, not recruiting
- Non-Small Cell Lung Cancer
- Selpercatinib
- +4 more
-
Berazategui, Buenos Aires, Argentina
- +195 more
Jan 30, 2023
NSCLC Trial in Worldwide (Selpercatinib, Placebo)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- Selpercatinib
- Placebo
-
Santa Monica, California
- +206 more
Dec 27, 2022
Non Small Cell Lung Cancer, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (Selpercatinib)
Available
- Non Small Cell Lung Cancer
- +6 more
- Selpercatinib
-
Goodyear, Arizona
- +67 more
Aug 17, 2022
Hematopoietic and Lymphoid Cell Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- +37 more
- Selpercatinib
-
Birmingham, Alabama
- +171 more
Aug 24, 2022